Categories: News

Leveljump Healthcare Corp. Terminates Agreement to Acquire Additional Shares in Real Time Medical Inc.

Toronto, Ontario–(Newsfile Corp. – July 5, 2022) – Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“Leveljump” or the “Company“), a Canadian leader in B2B telehealth solutions, announces that it will not be proceeding with its acquisition of 7127651 Canada Inc. as originally announced on April 26, 2022. Had the transaction closed, it would have resulted in Leveljump indirectly acquiring additional shares in Real Time Medical Inc. (“RTM”).

Although the Company obtained TSXV approval, it was unable to proceed with the transaction as a result of certain corporate actions taken against the Company by RTM to impede closing. In response to the conduct of RTM, the Company has commenced legal proceedings in the Ontario Superior Court of Justice against RTM and its management under court file no. CV-22-00683214-00CL.

As at the date hereof, Leveljump owns a 25.21% interest in RTM.

About Leveljump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) is building a national telehealth medical company and brand, currently by providing teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP owns and operates independent healthcare facilities (IHF’s) focused on diagnostic imaging.

ON BEHALF OF THE BOARD OF DIRECTORS OF

LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler, Chief Executive Officer
info@leveljumphealthcare.com
(833) 840-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the Company’s business plans and the outlook of the Company’s industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/130049

Staff

Recent Posts

Geek+ implements first Tote-to-Person project in Italy for pharmaceutical chain

DUSSELDORF, Germany, June 27, 2024 /PRNewswire/ -- Geekplus, the global leader in mobile robot and…

2 hours ago

UNGUESS strengthens its international footprint by joining forces with Ferpection

Ferpection, a French company active in User Research since 2014, will join UNGUESS's orbit starting…

2 hours ago

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Partner SMS Pharma will market the three products in the SiderAL® line under the trade name…

2 hours ago

LabTrace Completes the First Study Using its Blockchain-Based Data Authentication System, Designed to Ensure Data Integrity in Clinical Trials

Parkinson's disease research, sponsored by King's College London, verifies clinical observation data using the Algorand…

2 hours ago

Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

5 hours ago